Discover the Newest Way to Create Punchy, Flavorful Beverages
May 20, 2024 08:00 ET
|
John I. Haas, Inc.
YAKIMA, Wash., May 20, 2024 (GLOBE NEWSWIRE) -- Today, John I. Haas, Inc. (HAAS®), renowned leader in the global hops industry, announces the release of their bold, new, flavor and aroma product:...
Hopebridge Continues to Grow Autism Therapy Services by Opening Two New Locations in North Carolina
May 20, 2024 08:00 ET
|
Hopebridge
INDIANAPOLIS, IN, May 20, 2024 (GLOBE NEWSWIRE) -- As the prevalence of autism increases and the national focus is placed on early identification and intervention, Hopebridge Autism Therapy Centers...
Intercept Presents New Sub-Analyses of Phase 3 POISE Data Showcasing the Effect of OCA on Key Liver Biomarkers and Fibrosis in Patients with PBC at Digestive Disease Week® 2024
May 20, 2024 08:00 ET
|
Intercept Pharmaceuticals, Inc.
OCA normalizes levels of ALT and AST, liver biomarkers associated with poor clinical outcomes in a significantly higher proportion of patients after 12 months of treatment compared to placebo;...
Genius Group Announces Exercise of Warrants for $3.8 Million Gross Proceeds
May 20, 2024 08:00 ET
|
Genius Group Limited
SINGAPORE, May 20, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced the entry into...
Nasopharyngeal Cancer Market to Reach USD 1,136.28 Million by 2033; Biomarker Discovery and Personalized Treatment to Propel Growth
May 20, 2024 08:00 ET
|
The Brainy Insights
Newark, May 20, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 873.92 million in 2023 global nasopharyngeal cancer market will reach USD 1,136.28 million by 2033. Combination...
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
May 20, 2024 08:00 ET
|
Scorpius Holdings, Inc.
DURHAM, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced a significant...
InnovAge Welcomes John Koehn as Senior Vice President of External Affairs
May 20, 2024 08:00 ET
|
InnovAge
InnovAge Welcomes John Koehn as Senior Vice President of External Affairs
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile X Syndrome
May 20, 2024 08:00 ET
|
Spinogenix, Inc.
SAN DIEGO, May 20, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients...
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy
May 20, 2024 08:00 ET
|
APRINOIA Therapeutics, Inc.
CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics (“Aprinoia” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics and precision...
NV5 Strengthens Subscription-Based Services with Acquisition of myBIMteam
May 20, 2024 08:00 ET
|
NV5 Global, Inc.
HOLLYWOOD, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today...
- May 20, 2024 07:50 ET Global Peripheral Nerve Injury Market to Surpass USD 3.57 Billion by 2034, Exhibiting a CAGR of 7.76%
- May 20, 2024 07:45 ET Infrared Sauna Use in UCSF Clinical Trial Shows Promise in Combating Depression